布鲁顿氨酸激酶的共价抑制塑造了慢性淋巴细胞白血病中的免疫微环境
Daniel Medina-Gil1, Laura Palomo1, Víctor Navarro2
1Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra.
Haematologica
|March 13, 2025
概括
在慢性淋巴细胞白血病 (CLL) 中,易布鲁替尼治疗改善了T细胞功能,并减少了瘤细胞免疫抑制. 然而,CLL细胞通过发展突变和保持迁移能力来适应,这表明了潜在的抵抗机制.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在慢性淋巴细胞白血病 (CLL) 中,持续的易布鲁替尼治疗显示出瘤控制和T细胞增强.
- 了解对布鲁顿氨酸激酶 (BTK) 抑制的适应机制对于优化CLL治疗至关重要.
研究的目的:
- 为了研究CLL患者在前期IBRUTINIB治疗的前12个月的纵向多OMICS变化.
- 在BTK抑制下识别CLL细胞中的适应机制和潜在的抵抗途径.
主要方法:
- 对患者样本进行纵向多组学分析 (基因组学,转录组学,蛋白组学).
- 流细胞测量以评估T细胞子集和耗尽标记.
- 在体外功能测定T细胞增殖和细胞因子生产.
- 分析CLL细胞迁移,蛋白质表达和分子适应.
主要成果:
- 易布鲁替尼治疗使T细胞耗尽标记和Treg/Tfh比例正常化.
- T细胞显示激活/代谢基因表达减少,但刺激后细胞因子产量增加.
- 瘤细胞表现出免疫抑制,粘附和迁移的减少.
- 大约50%的患者在CLL细胞中发生了分子适应,保持了CXCL12/CXCR4迁移能力.
- 早期出现的BTK C481S突变与迁移性CLL细胞和独特的转录组特征 (mTOR-AKT,MYC) 有关.
- 高TMBIM6表达被确定为预后不佳的因素,其抗剂 (BIA) 诱导了亡并与ibrutinib协同作用.
结论:
- 综合的多奥米克分析揭示了易布鲁替尼对T细胞的早期免疫调节作用以及CLL细胞的适应性反应.
- 已识别的适应机制,包括BTK突变和独特的CLL细胞转录组学,为潜在的耐药性途径提供了洞察力.
- 高TMBIM6表达呈现出一种新的预后标志物,而TMBIM6对抗性代表了CLL的潜在治疗策略.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Receptor Tyrosine Kinases
11.6K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
11.6K
Cytotoxic T Cells-mediated Immune Response
720
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
720
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K


